Book contents
- Dispatches from the Land of Alzheimer’s
- Reviews
- Dispatches from the Land of Alzheimer’s
- Copyright page
- Dedication
- Lost in Thought
- Contents
- Acknowledgments
- Prologue
- 1 Physician Heal Thyself
- 2 Evaluating New Advances in Alzheimer’s Research
- 3 Alzheimer’s Dementia or Alzheimer’s Disease
- 4 The First Patient with Alzheimer’s Disease
- 5 Kidnapped in Kinshasa
- 6 Smell, Disgust, and Alzheimer’s
- 7 Apolipoprotein-4 (APOE-4)
- 8 Lost in the Fog of Alzheimer’s
- 9 My Father’s “Stuff”
- 10 Face Blindness during a Pandemic
- 11 Biomarkers for Alzheimer’s Disease
- 12 Olfactory Impairment in Covid-19 and Alzheimer’s
- 13 Alzheimer’s Disease and Work
- 14 Crossword Controversies
- 15 Can Loneliness Increase Risk for Dementia?
- 16 Excessive Laxative Use and Dementia
- 17 Dog Dementia (Canine Cognitive Dysfunction)
- 18 The Possible Role of Brain Inflammation in Alzheimer’s Disease May Be More Significant in APOE-4 Carriers
- 19 Surprisingly Good News about the Acetylcholinesterase Inhibitors (Donepezil, Rivastigmine, and Galantamine)
- 20 More about the Importance of Exercise
- 21 Rolling on the River
- 22 The MIND Diet Revisited
- 23 My Photographs, Then and Now
- 24 Does Cataract Surgery Really Decrease the Risk of Dementia?
- 25 Hearing Loss, Aphasia, and Dementia
- 26 To Sleep, Perchance to Dream
- 27 The Amyloid Hypothesis Is Not Dead, but It May Be Gasping for Breath
- 28 Could Lecanemab Offer a Ray of Hope?
- 29 A Fatal Case of Multiple Brain Hemorrhages Associated with Lecanemab
- 30 Cerebral Amyloid Angiopathy (CAA)
- 31 Hitting the Sweet Spot in the Spectrum of Alzheimer’s Disease for Future Trials of Anti-Amyloid Medications
- 32 Disappointing Results of Two Human Trials of Monoclonal Antibodies in Parkinson’s Disease
- 33 Repurposing Old Drugs for Alzheimer’s Treatment
- 34 Writing While Impaired
- 35 Spreading the Word
- 36 Saying Goodbye to Lizzie G
- 37 Amyloid and Tau PET Scans of My Brain
- 38 Running on a Field of Dreams
- 39 Living in the Moment with Alzheimer’s
- Index
- Plate Section (PDF Only)
- References
22 - The MIND Diet Revisited
Published online by Cambridge University Press: 19 January 2024
Book contents
- Dispatches from the Land of Alzheimer’s
- Reviews
- Dispatches from the Land of Alzheimer’s
- Copyright page
- Dedication
- Lost in Thought
- Contents
- Acknowledgments
- Prologue
- 1 Physician Heal Thyself
- 2 Evaluating New Advances in Alzheimer’s Research
- 3 Alzheimer’s Dementia or Alzheimer’s Disease
- 4 The First Patient with Alzheimer’s Disease
- 5 Kidnapped in Kinshasa
- 6 Smell, Disgust, and Alzheimer’s
- 7 Apolipoprotein-4 (APOE-4)
- 8 Lost in the Fog of Alzheimer’s
- 9 My Father’s “Stuff”
- 10 Face Blindness during a Pandemic
- 11 Biomarkers for Alzheimer’s Disease
- 12 Olfactory Impairment in Covid-19 and Alzheimer’s
- 13 Alzheimer’s Disease and Work
- 14 Crossword Controversies
- 15 Can Loneliness Increase Risk for Dementia?
- 16 Excessive Laxative Use and Dementia
- 17 Dog Dementia (Canine Cognitive Dysfunction)
- 18 The Possible Role of Brain Inflammation in Alzheimer’s Disease May Be More Significant in APOE-4 Carriers
- 19 Surprisingly Good News about the Acetylcholinesterase Inhibitors (Donepezil, Rivastigmine, and Galantamine)
- 20 More about the Importance of Exercise
- 21 Rolling on the River
- 22 The MIND Diet Revisited
- 23 My Photographs, Then and Now
- 24 Does Cataract Surgery Really Decrease the Risk of Dementia?
- 25 Hearing Loss, Aphasia, and Dementia
- 26 To Sleep, Perchance to Dream
- 27 The Amyloid Hypothesis Is Not Dead, but It May Be Gasping for Breath
- 28 Could Lecanemab Offer a Ray of Hope?
- 29 A Fatal Case of Multiple Brain Hemorrhages Associated with Lecanemab
- 30 Cerebral Amyloid Angiopathy (CAA)
- 31 Hitting the Sweet Spot in the Spectrum of Alzheimer’s Disease for Future Trials of Anti-Amyloid Medications
- 32 Disappointing Results of Two Human Trials of Monoclonal Antibodies in Parkinson’s Disease
- 33 Repurposing Old Drugs for Alzheimer’s Treatment
- 34 Writing While Impaired
- 35 Spreading the Word
- 36 Saying Goodbye to Lizzie G
- 37 Amyloid and Tau PET Scans of My Brain
- 38 Running on a Field of Dreams
- 39 Living in the Moment with Alzheimer’s
- Index
- Plate Section (PDF Only)
- References
Summary
Over the last 10 years or so, there have been an increasing number of studies that generally agree that people who regularly consume a plant-based, Mediterranean-style diet, are less likely to get Alzheimer’s dementia than those who do not. These studies have found nearly the same results in populations from around the world including the USA, Japan, Australia, Greece, and other European countries. The contents of the diets, age of participants, and extent of benefit may differ from study to study, but overall, those participants who follow a Mediterranean-style diet or one of the variants have between 35–50% less chance of getting Alzheimer’s or, in some studies, all-cause dementia.
- Type
- Chapter
- Information
- Dispatches from the Land of Alzheimer's , pp. 91 - 95Publisher: Cambridge University PressPrint publication year: 2024
References
Beydoun, MA, Beydoun, HA, Fanelli-Kuczmarski, MT, et al. Association of serum antioxidant vitamins and carotenoids with incident Alzheimer disease and all-cause dementia among US adults. Neurology 2022; 98: e2150–e2162. https://doi.org/10.1212/WNL.0000000000200289.CrossRefGoogle ScholarPubMed
Morris, MC, Tangney, CC, Wang, Y, Sacks, FM, Bennett, DA, Aggarwal, NT. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement 2015; 11: 1007–1014. https://doi.org/10.1016/j.jalz.2014.11.009. Epub 2015 Feb 11. PMID: 25681666; PMCID: PMC4532650 (open access).CrossRefGoogle ScholarPubMed
Hosking, DE, Eramudugolla, R, Cherbuin, N, et al. MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study. Alzheimers Dement 2019; 15: 581–589. https://doi.org/10.1016/j.jalz.2018.12.011.CrossRefGoogle ScholarPubMed
Holland, M, Agarwal, P, Wang, Y, et al. Dietary flavonols and risk of Alzheimer dementia. Neurology 2020; 94: e1749–e1756. https://doi.org/10.1212/WNL.0000000000008981.CrossRefGoogle ScholarPubMed
Holland, TM, Agarwal, P, Wang, Y, et al. Association of dietary intake of flavonols with changes in global cognition and several cognitive abilities. Neurology 2023; 100: e694–e702 https://doi.org/10.1212/WNL.0000000000201541.CrossRefGoogle ScholarPubMed
USDA Database for the Flavonoid Content of Selected Foods. Release 3.3 (March 2018). www.ars.usda.gov/ARSUserFiles/80400535/Data/Flav/Flav3.3.pdf (open access) accessed March 15, 2023.Google Scholar
Flores, M, Saravia, C, Vergara, CE, et al. Avocado oil: Characteristics, properties, and applications. Molecules 2019; 24: 2172. https://doi.org/10.3390/molecules24112172. PMID: 31185591; PMCID: PMC6600360 (open access).CrossRefGoogle ScholarPubMed
Metcalfe-Roach, A, Yu, AC, Golz, E, et al. MIND and Mediterranean diets associated with later onset of Parkinson’s disease. Movement Disorders 2021; 36: 977–984. https://doi.org/10.1002/mds.28464 (open access).CrossRefGoogle ScholarPubMed
Zhang, X, Molsberry, SA, Yeh, T-A, et al. Intake of flavonoids and flavonoid-rich foods and mortality risk among individuals with Parkinson disease – A prospective cohort study. Neurology 2022; 98: e1064–e1076. https://doi.org/10.1212/WNL.0000000000013275.CrossRefGoogle ScholarPubMed